Inari Medical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Inari Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
  • Inari Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$18.4M, a 681% decline year-over-year.
  • Inari Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$78.6M, a 2738% decline year-over-year.
  • Inari Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.64M, a 94.4% increase from 2022.
  • Inari Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29.3M, a 397% decline from 2021.
  • Inari Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $9.84M, a 28.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$78.6M -$18.4M -$21.5M -681% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-28
Q2 2024 -$57.1M -$31.3M -$33.4M -1604% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-28
Q1 2024 -$23.6M -$24.2M -$22M -991% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-28
Q4 2023 -$1.64M -$4.67M +$1.13M +19.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$2.77M $3.16M +$13.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-28
Q2 2023 -$16.1M $2.09M +$12.3M Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-28
Q1 2023 -$28.4M -$2.22M +$911K +29.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-28
Q4 2022 -$29.3M -$5.8M -$6.91M -624% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$22.4M -$10.2M -$7.35M -262% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$15M -$10.2M -$14.3M -350% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 -$758K -$3.13M -$10.6M -142% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 $9.84M $1.11M -$5.88M -84.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $15.7M -$2.8M -$9.3M -143% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $25M $4.07M +$7.87M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-02
Q1 2021 $17.1M $7.47M +$3.36M +81.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-02
Q4 2020 $13.8M $6.99M +$6.63M +1868% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $7.16M $6.5M +$6.13M +1675% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.03M -$3.8M -$2.84M -294% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 $3.87M $4.11M +$5.06M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$1.19M $355K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $366K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$965K Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$948K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.